APA (7th ed.) Citation

N, H., NM, G., MH, E., AM, E., AM, R., ZH, E., . . . TA, G. (2020). Serum 14-3-3η protein is associated with clinical and serologic features of Sjögren's syndrome in patients with systemic lupus erythematosus: A cross-sectional analysis. Clinical rheumatology, 39(9), 2603. https://doi.org/10.1007/s10067-020-05033-3

Chicago Style (17th ed.) Citation

N, Hammam, Gamal NM, Elzohri MH, Elsonbaty AM, Rashed AM, Eldaly ZH, Tarik D, and Gheita TA. "Serum 14-3-3η Protein Is Associated with Clinical and Serologic Features of Sjögren's Syndrome in Patients with Systemic Lupus Erythematosus: A Cross-sectional Analysis." Clinical Rheumatology 39, no. 9 (2020): 2603. https://doi.org/10.1007/s10067-020-05033-3.

MLA (9th ed.) Citation

N, Hammam, et al. "Serum 14-3-3η Protein Is Associated with Clinical and Serologic Features of Sjögren's Syndrome in Patients with Systemic Lupus Erythematosus: A Cross-sectional Analysis." Clinical Rheumatology, vol. 39, no. 9, 2020, p. 2603, https://doi.org/10.1007/s10067-020-05033-3.